Table 2.
Not adjusted | With adjustmenta | |||||
---|---|---|---|---|---|---|
OR | 95% CI | p | OR | 95% CI | p | |
BMQ-subscales | ||||||
General beliefs | ||||||
Overuse | 0.56 | 0.34–0.93 | .02 | 0.42 | 0.22–0.80 | <.01 |
Harm | 0.55 | 0.30–1.01 | .05 | 0.43 | 0.21–0.88 | .02 |
Utility | 0.40 | 0.80–2.78 | .21 | 1.39 | 0.68–2.82 | .36 |
Specific beliefs | ||||||
Necessity | 2.04 | 1.29–3.22 | <.01 | 2.97 | 1.54–5.73 | <.01 |
Concerns | 0.83 | 0.50–1.38 | .47 | 0.68 | 0.37–1.28 | .24 |
OR odds ratio, 95% CI 95% confidence interval, BMQ Beliefs about Medicines-Questionnaire, MARS Medication Adherence Report-Scale
aModels adjusted for age, education, number of prescribed inhalers, number of prescribed pills, distance to provider of asthma treatment, ACQ score (Asthma Control Questionnaire) score, HADS (Hospital Anxiety and Depression Scale) depression score, HADS anxiety score adjusted models: N: 173-177; Nagelkerke’s R2: .31–.39